BlackRock Fund Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

BlackRock Fund Advisors’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$23.4M	Buy	1,232,630 +228,805	+23%	+$4.37M	﹤0.01%	2091
2016 Q3	$19.6M	Buy	1,003,825 +251,804	+33%	+$4.26M	﹤0.01%	2071
2016 Q2	$11.3M	Buy	752,021 +113,592	+18%	+$1.43M	﹤0.01%	2344
2016 Q1	$5.87M	Buy	638,429 +12,011	+2%	+$146K	﹤0.01%	2657
2015 Q4	$12.1M	Buy	626,418 +260,575	+71%	+$4.52M	﹤0.01%	2337
2015 Q3	$5.44M	Buy	365,843 +164	+0%	+$3.85K	﹤0.01%	2759
2015 Q2	$8.01M	Buy	365,679 +194,389	+113%	+$3.92M	﹤0.01%	2636
2015 Q1	$3.86M	Buy	171,290 +7,031	+4%	+$163K	﹤0.01%	2959
2014 Q4	$3.32M	Buy	164,259 +54,179	+49%	+$982K	﹤0.01%	3046
2014 Q3	$2.01M	Sell	110,080 -4,778	-4%	-$69.2K	﹤0.01%	3122
2014 Q2	$1.55M	Sell	114,858 -9,249	-7%	-$126K	﹤0.01%	3139
2014 Q1	$2.04M	Buy	+124,107	New	+$2.15M	﹤0.01%	3138

Other funds holding FLXN

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Fund Advisors's FLXN Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Flexion Therapeutics, Inc. (FLXN) stake by 23% in Q4 2016, buying an estimated $4.37M and bringing the position to 1,232,630 shares worth $23.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2091.

BlackRock Fund Advisors first reported a position in FLXN in Q1 2014 and has held it in 12 quarters since. 94 funds tracked by Wall St. Rank hold FLXN as of Q4 2016.

BlackRock Fund Advisors held 1,232,630 shares of Flexion Therapeutics, Inc. worth $23.4M as of Q4 2016.
BlackRock Fund Advisors bought 228,805 Flexion Therapeutics, Inc. shares in Q4 2016, an estimated $4.37M.
Flexion Therapeutics, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2091 holding.
BlackRock Fund Advisors first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and has held it in 12 quarters since.
94 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.